Xolair gains final NICE approval PharmaTimes It is to be used as an add-on to optimised standard therapy for those people who need continuous or frequent treatment with oral corticosteroids (defined as four or more courses in the previous year). NICE had been minded not to recommend the drug in ... Xolair gets asthma green light from NICE |
